Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction
- 1 September 1988
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (9) , 571-575
- https://doi.org/10.1016/0002-9149(88)90657-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Risk factors for the development of proarrhythmic eventsThe American Journal of Cardiology, 1987
- Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarctionThe American Journal of Cardiology, 1986
- Encainide for ventricular arrhythmias: Placebo-controlled and standard comparison trialsThe American Journal of Cardiology, 1986
- Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptomsThe American Journal of Cardiology, 1986
- Treatment of resistant ventricular tachycardia with flecainide acetateThe American Journal of Cardiology, 1986
- Antiarrhythmic treatment: An overviewThe American Journal of Cardiology, 1984
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Encainide for refractory ventricular tachyarrhythmiaThe American Journal of Cardiology, 1983
- Can we prevent sudden cardiac death?The American Journal of Cardiology, 1982
- Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.Circulation, 1981